Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
130 E 18th St
1bc
New York, NY 10003Phone+1 212-420-1566Fax+1 212-420-8869- Is this information wrong?
Education & Training
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Urology, 1974 - 1978
- New York-Presbyterian/QueensInternship, Transitional Year, 1973 - 1974
- Nishtar Medical CollegeClass of 1963
Certifications & Licensure
- FL State Medical License 2014 - 2025
- NY State Medical License 1976 - 2018
- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- MEF-2 isoforms' (A-D) roles in development and tumorigenesis.Madugula, K.,Mulherkar, R.,Khan, Z. K.,Chigbu, D. I.,Patel, D.,Harhaj, E. W.,Jain, P.> ;Oncotarget. 2019 May 21
- Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.Chigbu, D. I.,Jain, P.,Crumley, B. L.,Patel, D.,Khan, Z. K.> ;J. Neurovirol.. 2019 Jan 30
- In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.Mulherkar, R.,Karabudak, A.,Ginwala, R.,Huang, X.,Rowan, A.,Philip, R.,Murphy, E. L.,Clements, D.,Ndhlovu, L. C.,Khan, Z. K.,Jain, P.> ;Vaccine. 2018 Jul 15
- Join now to see all
Journal Articles
- In Vivo and in Vitro Immunogenicity of Novel MHC Class I Presented Epitopes to Confer Protective Immunity Against Chronic HTLV-1 InfectionZafar K Khan, Pooja Jain, ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: